These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17102615)

  • 1. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1.
    Lu HR; Wang X; Wang Y
    Cell Cycle; 2006 Oct; 5(20):2364-70. PubMed ID: 17102615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.
    Horton JK; Stefanick DF; Zeng JY; Carrozza MJ; Wilson SH
    DNA Repair (Amst); 2011 Feb; 10(2):225-34. PubMed ID: 21130714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q; Li Y; Deng J; Zhang Z
    Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
    Heacock ML; Stefanick DF; Horton JK; Wilson SH
    DNA Repair (Amst); 2010 Aug; 9(8):929-36. PubMed ID: 20573551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation.
    Wang X; Li GC; Iliakis G; Wang Y
    Cancer Res; 2002 Nov; 62(21):6031-4. PubMed ID: 12414624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
    Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
    DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ku-dependent non-homologous end-joining but not other repair pathway is inhibited by high linear energy transfer ionizing radiation.
    Wang H; Wang X; Zhang P; Wang Y
    DNA Repair (Amst); 2008 May; 7(5):725-33. PubMed ID: 18325854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-Ribose) polymerase-1 and DNA-dependent protein kinase have equivalent roles in double strand break repair following ionizing radiation.
    Mitchell J; Smith GC; Curtin NJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1520-7. PubMed ID: 19931734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
    Horton JK; Stefanick DF; Naron JM; Kedar PS; Wilson SH
    J Biol Chem; 2005 Apr; 280(16):15773-85. PubMed ID: 15701627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHK1 affecting cell radiosensitivity is independent of non-homologous end joining.
    Wang H; Hu B; Liu R; Wang Y
    Cell Cycle; 2005 Feb; 4(2):300-3. PubMed ID: 15655357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G; Godon C; Fernet M; Giocanti N; Mégnin-Chanet F; Favaudon V
    Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
    Godon C; Cordelières FP; Biard D; Giocanti N; Mégnin-Chanet F; Hall J; Favaudon V
    Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.
    Horton JK; Stefanick DF; Kedar PS; Wilson SH
    DNA Repair (Amst); 2007 Jun; 6(6):742-50. PubMed ID: 17292679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
    Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
    Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
    Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
    DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q; Li Y; Lai Y; Zhang Z
    J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.